These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8067019)

  • 1. [The effect of membrane-stabilizing therapy on the status of the hemostatic system in patients with glomerulonephritis with a hematuric component].
    Pyrih LA; Kolesnyk MO; Lapchyns'ka II; Dudar IO
    Lik Sprava; 1994 Jan; (1):55-8. PubMed ID: 8067019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antithrombotic therapy in correcting hemostatic disorders in patients with chronic glomerulonephritis].
    Nazar PS; Badiuk RA
    Vrach Delo; 1990 Mar; (3):18-20. PubMed ID: 2368351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The characteristics of the lipid peroxidation processes in patients with glomerulonephritis and a hematuric component].
    Dudar IO; Kolesnyk MO; Nikulina HH
    Lik Sprava; 1992 Aug; (8):48-52. PubMed ID: 1475926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemostasis in the hematuric form of chronic glomerulonephritis].
    Kanatbaeva AB; Naumova VI; Potapova IN; Mustafina SM
    Pediatriia; 1985 Oct; (10):21-4. PubMed ID: 4080461
    [No Abstract]   [Full Text] [Related]  

  • 5. [Some blood coagulation indices and the fibrinolytic activity in the hematuria form of glomerulonephritis in children].
    Artemenko SP; Andreieva EIa
    Pediatr Akus Ginekol; 1971; 4():26-7. PubMed ID: 5150408
    [No Abstract]   [Full Text] [Related]  

  • 6. [The significance of lipid peroxidation in the chronicity of glomerulonephritis with a hematuric component].
    Dudar IO; Kolesnyk MO; Nikulina HH; Pyrih LA
    Lik Sprava; 1993; (5-6):84-7. PubMed ID: 8209509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathology of the hemostatic system in the acute period of an ischemic stroke and the possibilities for its therapeutic correction].
    Shutov AA; Karakulova IuV; Chudinov AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 1996; 96(1):45-9. PubMed ID: 8677718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of reflexotherapy on the hemostatic system of patients with glomerulonephritis].
    Holub TI
    Lik Sprava; 1999; (3):157-61. PubMed ID: 10474969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blood coagulation and excretion of coagulation and fibrinolysis factors with urine of patients with diffuse glomerulonephritis].
    Zorina SS; Krasik IaD
    Ter Arkh; 1974; 46(7):54-62. PubMed ID: 4408677
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinico-pathogenetic characteristics of hematuric glomerulonephritis].
    Tov NL; Nekipelova VI; Savitskaia IV; Chernykh ER; Mozchan EA
    Ter Arkh; 1989; 61(6):19-24. PubMed ID: 2799707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effect of sodium ions in vitro on the hemostatic balance of whole blood in patients with ischemic heart disease and hypercoagulation].
    Tolstopiatov SM
    Lik Sprava; 1997; (5):56-9. PubMed ID: 9491698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of intrinsic fibrinolytic system activation in pathogenesis of hemostasis disturbances in hemodialyzed patients with chronic renal failure.
    Bronisz M; Rość D; Bronisz A; Manitius J; Nartowicz E
    Ren Fail; 2004 May; 26(3):223-9. PubMed ID: 15354969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The efficacy of treating glomerulonephritis patients with a hematuria component].
    Pyrih LA; Dudar IO; Kolesnyk MO
    Lik Sprava; 1992 Mar; (3):3-6. PubMed ID: 1413681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of therapeutic plasmapheresis on the hemostatic system of patients with chronic glomerulonephritis and the nephrotic syndrome].
    Kolesnyk MO; Lapchyns'ka II; Dudar IO; Velychko MB
    Lik Sprava; 1993; (2-3):79-81. PubMed ID: 8191743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Specific features of blood coagulation system and fibrinolysis in patients with glomerulonephritis against the background of heparin treatment].
    Panchenko VM; Gilunova NI; Kozhomkulova BZh; Tsitron AI; Liapina LA
    Klin Med (Mosk); 1977 May; 55(5):116-22. PubMed ID: 875322
    [No Abstract]   [Full Text] [Related]  

  • 16. [Functional status of the hemostatic and fibrinolytic systems in patients with clinical variants of chronic glomerulonephritis].
    Miagkov II; Nazar PS
    Ter Arkh; 1989; 61(11):123-6. PubMed ID: 2633374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The evaluation of hemostatic disorders in patients with systemic lupus erythematosus].
    Arshinov AV; Lapin VA; Raĭt IuA
    Ter Arkh; 1999; 71(5):38-40. PubMed ID: 10399229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thrombocyto- and coagulopathies in patients with diabetic glomerulosclerosis and chronic glomerulonephritis].
    Lapchyns'ka II; Bielyts'ka HO; Lezhen TI; Ishchenko VM; Fedorova NIe
    Lik Sprava; 1996; (3-4):74-7. PubMed ID: 9035889
    [No Abstract]   [Full Text] [Related]  

  • 19. [Blood coagulation disorders in glomerulonephritis].
    Sokratov NV; Safronova TA
    Urol Nefrol (Mosk); 1979; (1):64-71. PubMed ID: 442301
    [No Abstract]   [Full Text] [Related]  

  • 20. [The blood coagulation potential in experimental nephrotoxic glomerulonephritis].
    Nazar PS; Miagkov II
    Patol Fiziol Eksp Ter; 1990; (1):45-7. PubMed ID: 2352782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.